Fundraising Fox
/Companies
Sign in

bioProtonics

Santa Barbara, US · Founded 2018 · Delaware corporation

Find your way into bioProtonics

Sign up to see every warm intro you have to bioProtonics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the bioProtonics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

bioProtonics develops Magnetic Resonance Histopathology (MRH), an MRI-based software method that non-invasively measures tissue microstructure at a sub-millimeter level to help radiologists detect early signs of cancer and other diseases. The technology integrates with standard MRI scans and DICOM workflows and uses AI analysis as a "digital biopsy" aimed at reducing reliance on surgical biopsies.

AI & Machine LearningHealthtechMedical Devices

Founders & leadership

FFForrest Fleming
Forrest FlemingChief Executive Officer2023–2025Forrest Fleming founded and led TrueVision Surgical (2006-2018), a digital surgery platform acquired by Alcon, and ScentAir Technologies (2000-2005), a scent-marketing company later acquired by Parthenon PE. He holds a B.S. in Industrial Technology from Cal Poly San Luis Obispo and has held senior sales and marketing roles at Parametric Technology, Paracel, and Cinesite.
DR
Daniel R. DoironExecutive
WT
W. Timothy JamesNamed on SEC filing
CW
Charles W WincklerNamed on SEC filing

Board

KL
Kristin LoomisBoard director
RS
Ryan ShieldsBoard director
TW
Timothy W. JamesBoard director

Reported raises · per SEC filings

Form D private placements

$9.6M disclosed across 10 rounds · 2019–2025

▶$1MraisedApr 2026 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy W. JamesDirector
  • Kristin LoomisDirector
  • A. Burton TripathiExecutive Officer, Director
  • Ryan ShieldsDirector
  • Daniel R. DoironExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$1M
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedDec 2024 · 18 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Forrest FlemingExecutive Officer, Director
  • Kristin LoomisDirector
  • Ryan ShieldsDirector
  • Daniel R. DoironExecutive Officer, Director
  • Timothy W. JamesDirector
Offering amount
$2.7M
Amount sold
$2.7M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedApr 2024 · 13 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan ShieldsDirector
  • KRISTIN LOOMISDirector
  • Forrest FlemingExecutive Officer, Director
  • TIMOTHY W. JAMESDirector
  • DANIEL R. DOIRONExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$1.9M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$74.4KraisedApr 2023 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Forrest FlemingExecutive Officer
  • Timothy W. JamesDirector
  • Daniel R. DoironExecutive Officer, Director
  • Kristin LoomisDirector
Offering amount
$74.4K
Amount sold
$74.4K
First sale
Apr 2023
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$108.9KraisedJan 2023 · 3 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel R. DoironExecutive Officer, Director
  • Kristin LoomisDirector
  • Timothy W. JamesDirector
  • Forrest FlemingExecutive Officer
Offering amount
$108.9K
Amount sold
$108.9K
First sale
Jan 2023
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedAug 2021 · 5 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles W. WincklerExecutive Officer
  • Timothy JamesDirector
  • Kristin LoomisDirector
  • Daniel R. DoironExecutive Officer, Director
Offering amount
$1M
Amount sold
$1M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$837KraisedJul 2021 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • W. Timothy JamesDirector
  • Kristin LoomisDirector
  • Daniel R. DoironExecutive Officer, Director
  • Charles W WincklerExecutive Officer
Offering amount
$1M
Amount sold
$837K
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$577KraisedMar 2021 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel R. DoironExecutive Officer, Director
  • W. Timothy JamesDirector
  • Kristin LoomisDirector
  • Charles W WincklerExecutive Officer
Offering amount
$1M
Amount sold
$577K
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2016$150K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does bioProtonics do?
bioProtonics develops Magnetic Resonance Histopathology (MRH), an MRI-based software method that non-invasively measures tissue microstructure at a sub-millimeter level to help radiologists detect early signs of cancer and other diseases. The technology integrates with standard MRI scans and DICOM workflows and uses AI analysis as a "digital biopsy" aimed at reducing reliance on surgical biopsies.
How much funding has bioProtonics raised?
bioProtonics has disclosed $9.6M raised across 10 rounds.
Where is bioProtonics headquartered?
bioProtonics is headquartered in Santa Barbara, US.